Cargando…

Metabolomic Perspectives in Antiblastic Cardiotoxicity and Cardioprotection

Despite advances in supportive and protective therapy for myocardial function, cardiovascular diseases due to antineoplastic therapy—primarily cardiomyopathy associated with contractile dysfunction—remain a major cause of morbidity and mortality. Because of the limitations associated with current th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deidda, Martino, Mercurio, Valentina, Cuomo, Alessandra, Noto, Antonio, Mercuro, Giuseppe, Cadeddu Dessalvi, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801977/ https://www.ncbi.nlm.nih.gov/pubmed/31590338 http://dx.doi.org/10.3390/ijms20194928

Ejemplares similares

Metabolomic Profiles on Antiblastic Cardiotoxicity: New Perspectives for Early Diagnosis and Cardioprotection
por: Fazzini, Luca, et al.
Publicado: (2022)

Metabolomic Approach to Redox and Nitrosative Reactions in Cardiovascular Diseases
por: Deidda, Martino, et al.
Publicado: (2018)

Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
por: Mercurio, Valentina, et al.
Publicado: (2020)

The Echocardiographic Parameters of Systolic Function Are Associated with Specific Metabolomic Fingerprints in Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy
por: Deidda, Martino, et al.
Publicado: (2021)

Right Ventricular Subclinical Dysfunction in SLE Patients Correlates with Metabolomic Fingerprint and Organ Damage
por: Deidda, Martino, et al.
Publicado: (2023)

Metabolomic approach to profile functional and metabolic changes in heart failure
por: Deidda, Martino, et al.
Publicado: (2015)

Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors
por: Caocci, Giovanni, et al.
Publicado: (2020)

ANTIBLASTIC IMMUNITY
por: Dochez, A. R., et al.
Publicado: (1916)

Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study
por: Deidda, Martino, et al.
Publicado: (2022)

Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease
por: Deidda, Martino, et al.
Publicado: (2017)

STUDIES ON ANTIBLASTIC IMMUNITY
por: Blake, Francis G.
Publicado: (1917)

Early Right Ventricular Dysfunction in Highly Selected (Totally Free from Cardiovascular Risk Factors and Other Comorbidities) Human Immunodeficiency Virus Patients: A Pilot Study with Advanced Echocardiography
por: Deidda, Martino, et al.
Publicado: (2018)

Animal Models in Studies of Cardiotoxicity Side Effects from Antiblastic Drugs in Patients and Occupational Exposed Workers
por: Lamberti, Monica, et al.
Publicado: (2014)

Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state
por: Deidda, Martino, et al.
Publicado: (2019)

Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective
por: Varricchi, Gilda, et al.
Publicado: (2018)

Vascular Damage – Coronary Artery Disease
por: Cadeddu Dessalvi, Christian, et al.
Publicado: (2020)

A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology
por: Spallarossa, Paolo, et al.
Publicado: (2016)

A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology
por: Maurea, Nicola, et al.
Publicado: (2016)

Metabolomics and Cardiology: Toward the Path of Perinatal Programming and Personalized Medicine
por: Pintus, Roberta, et al.
Publicado: (2017)

Inverted Takotsubo Cardiomyopathy Induced by Dobutamine Stress Echocardiography with Atypical Presentation
por: Cadeddu, Christian, et al.
Publicado: (2011)

Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway
por: Madonna, Rosalinda, et al.
Publicado: (2020)

Sex‐related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model
por: Madonna, Rosalinda, et al.
Publicado: (2022)

ANTIBLASTIC PHENOMENA IN ACTIVE ACQUIRED IMMUNITY AND IN NATURAL IMMUNITY TO PNEUMOCOCCUS
por: Barber, M. A.
Publicado: (1919)

Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects
por: Cadeddu, Christian, et al.
Publicado: (2013)

Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish
por: Zheng, Chuanrui, et al.
Publicado: (2020)

The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
por: Timm, Kerstin N., et al.
Publicado: (2020)

Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors
por: Meloni, Antonella, et al.
Publicado: (2023)

Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review
por: Piras, Cristina, et al.
Publicado: (2021)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
por: Küçük, Murathan, et al.
Publicado: (2020)

Cardiovascular Effects of Snake Toxins: Cardiotoxicity and Cardioprotection
por: Averin, A. S., et al.
Publicado: (2021)

Cardioprotective Strategies from Cardiotoxicity in Cancer Patients: A Comprehensive Review
por: Kourek, Christos, et al.
Publicado: (2022)

Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
por: Hahn, Virginia Shalkey, et al.
Publicado: (2014)

Cardioprotection From Cardiotoxicity: The Quest for the Holy Grail Goes On
por: Oliveira, Guilherme H.
Publicado: (2019)

Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Argun, Mustafa, et al.
Publicado: (2016)

Cardioprotective effect of metformin against doxorubicin cardiotoxicity in rats
por: Tseng, Yi-Tang
Publicado: (2016)

Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection
por: Morelli, Marco Bruno, et al.
Publicado: (2022)

Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients
por: Cadeddu, Christian, et al.
Publicado: (2014)

Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance
por: Cadeddu, Christian, et al.
Publicado: (2016)

Cardioprotective Potentials of Plant-Derived Small Molecules against Doxorubicin Associated Cardiotoxicity
por: Ojha, Shreesh, et al.
Publicado: (2016)

The broad spectrum of cardiotoxicities from immunotherapies
por: Iengo, Martina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m7h9335quq7uaefv8hvj56sfqa